Delivery Order SPE2DR25D6028-SPE2DR26FAQRM
- Not listed
- The Defense Logistics Agency (DLA) awarded a $4,150.39 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,331.36 to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL formulation) on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of the vendor's extensive pharmaceutical supply relationship with DLA's Medical Supply Chain. The award specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML) on September 10, 2025, with a ceiling value of $13,268.58. This firm fixed-price delivery order, which carries an ultimate completion date of September 11, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a $2,741.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 ML) with an ultimate completion date of August 25, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $5,463.02 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) under a firm fixed price contract. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This award represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,671.82 to AmerisourceBergen Drug Corp for RotaTeq Vaccine 2ML on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $3,844.54 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of RotaTeq vaccine (2ML). The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside contract utilizes the standard delivery order mechanism, with performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) with a ceiling value of $2,741.22. This firm fixed-price delivery order, issued on August 14, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract is set for completion by August 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,286.08 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine in 2ML units. The contract, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, operates under firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $3,126.67 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on September 16, 2025, with completion targeted for September 17, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's distribution facility in Conshohocken,...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FAQRMDelivery Order
The Defense Logistics Agency awarded a $27,372.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RotaTeq suspension (2ML, 10 count) on October 20, 2025, with completion by October 21, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation and represents a competitive award to the pharmaceutical distributor. Performance will occur at the company's corporate office in Conshohocken, Pennsylvania. RotaTeq is a rotavirus vaccine commonly used in military and federal healthcare systems to prevent rotavirus gastroenteritis. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, leverages its comprehensive IDC vehicle with DLA to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs globally. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements through open competition, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.4k | 10/20/25 |